NTRS — Northern Trust Corporation

The market read is a cautious Hold: the 2026-10-21 Q3 print showed adjusted EPS of $3.40 versus ~$2.87 consensus, revenue up ~13% YoY, 8% trust/investment fee growth, and +600 bps operating leverage, but forward consensus EPS of $11.53 is below TTM EPS of $13.33 and analysts worry about sequential moderation and a mixed Q4 outlook. As of 2026-10-21, the stock was 5.6% lower over the prior month and 5.5% lower over three months, with the consensus rating Hold and a $184.71 average price target.

Underlying operating momentum is stable-to-improving, but the raw FMP quarterly series is noisy. Q3 2026 revenue was $2.294B versus $4.212B in Q2 2026, and the deterministic score itself flags a -46% sequential revenue move that looks like a presentation/divestiture distortion rather than organic collapse; the live brief says Q3 revenue actually rose ~13% YoY. Cleaner data: adjusted EPS of $3.40 beat consensus, trust/investment servicing fees rose 8% YoY to $1.37B, and operating leverage was positive by more than 600 bps. The multi-quarter EPS path from Q4 2023 ($0.52) through Q4 2025 ($2.42) to Q3 2026 ($3.51 GAAP, $3.40 adjusted) shows recovery from a weak 2023-24 base, but Q2 2026 ($4.23) looks inflated by one-offs and forward EPS is still expected to fall to $11.53 next FY. Net: not a structural acceleration; a quality franchise with noisy reported results and normalizing earnings.

As of 2026-10-21, the stock at $167.09 trades at 12.9x TTM EPS, below its 5-year average P/E of 14.73x, but that TTM figure includes elevated/one-off earnings. On next-FY consensus EPS of $11.531, the forward P/E is ~14.5x, only slightly below the 5-year average, while P/S is 2.20x versus a 2.15x 5-year average—so valuation is fair to modestly cheap, not deeply discounted. The 0.258 PEG looks optically cheap but is not reliable here because next-FY EPS is expected to decline; P/B is 2.44x and the dividend yield is 1.76% on the stated payout (the newly raised $0.88 quarterly dividend would be roughly 2.1% at $167.09).

At $167.09 as of 2026-10-21, the stock is trading at ~14.5x next-FY EPS of $11.53, so it is not pricing in a collapse but also not offering a big cushion. The Q3 beat is real, but because next-FY EPS is below TTM EPS, the market is already looking past one-off gains and demanding evidence that fee growth and buybacks can offset NII normalization. If consensus EPS stabilizes or moves up after Q3, a 15-15.5x multiple supports the high-$170s; if rate cuts pressure NII and estimates drift toward $11 or below, 13-14x implies roughly $143-$154. The key tell is post-Q3 EPS revision direction, not the headline beat.

As of 2026-10-21, RSI(14) was 45.0—neutral, neither oversold nor overbought. The price at $167.09 was 0.13% below its 20-day SMA, 5.28% below its 50-day SMA, and 2.59% above its 200-day SMA; the one-week return was +3.83%, but the one-month and three-month returns were -5.64% and -5.48%. That is a short-term bounce inside a medium-term pullback, still range-bound: not an oversold entry signal, and a reclaim of the 50-day would improve the setup while a break below the 200-day would weaken it.

• Interest-rate path and NII sensitivity: rate cuts and deposit betas affect cash-sweep yields and net interest income; Northern Trust has managed funding costs but remains exposed.
• Capital-market levels: fee revenue is tied to AUC/A and AUM, so equity and fixed-income valuations directly influence trust, investment, and servicing fees.
• Regulatory capital requirements: Basel-endgame iterations and compliance costs can constrain capital-return flexibility, though current capital generation is strong.
• Wealth and asset-servicing consolidation: the UBS/former Credit Suisse fund administration transfer is both a growth opportunity and an integration/execution risk.
• Global market/currency backdrop: a meaningful share of assets and clients are outside the U.S., so dollar moves and non-U.S. market performance can affect reported results.

• Integration and client onboarding from the UBS/former Credit Suisse fund administration businesses in Switzerland and Luxembourg.
• Execution of the newly authorized share repurchase program and the recently raised $0.88 quarterly dividend.
• Q4 2026 earnings on 2027-01-21 and any post-Q3 consensus EPS revisions.
• Rate-cut trajectory and its effect on NII, deposit betas, and cash-sweep revenue.
• Continued net client inflows and market-level gains supporting AUC/A and AUM.

• Forward EPS of $11.53 is below TTM EPS of $13.33; worse-than-expected earnings normalization would undercut the valuation case.
• Rate cuts could compress NII and cash-sweep yields more than expected.
• A market downturn would reduce AUC/A and AUM, pressuring fee revenue and operating leverage.
• Regulatory capital changes or compliance costs could limit buybacks/dividends.
• Integration risk and competition in wealth/asset servicing could slow the expected growth from recent mandates.

Northern Trust is a high-quality custody and wealth franchise with strong Q3 2026 fee momentum, positive operating leverage, and a respectable 13.4% ROE, but at $167.09 as of 2026-10-21 it trades near its own forward-earnings average rather than at a clear discount. The deterministic score is too harsh because it penalizes bank-like cash-flow volatility and distorted reported revenue, yet the forward EPS decline and Hold consensus keep the risk/reward from being compelling. I would call it fairly valued with limited margin of safety, not a fresh buy.

I applied a 15.0x P/E to next-FY consensus EPS of $11.531, giving $172.97 (rounded to $173.00). The multiple is a modest premium to the 5-year average P/E of 14.73x to reflect Q3 2026 fee growth and +600 bps operating leverage, but it is held below the analyst target because forward EPS is expected to decline from TTM and rate-cut/NII risk remains.